Signet Healthcare Partners has completed a growth capital investment in LAXAI, according to a news release.
LAXAI, with U.S. offices in Massachusetts and California, is an integrated contract research, development and manufacturing organization. Founded in 2007, the company’s solutions include drug discovery, chemical process research and development and manufacturing for pharmaceutical, biotech and specialty chemicals companies located throughout the world.
Signet, based in New York and founded in 1998, is a private equity fund that focuses on investments in commercial-stage healthcare companies, specifically pharmaceutical sector and medical technology companies.
Terms of the investment were not disclosed.